Atossa Therapeutics Inc (NASDAQ:ATOS)
| 0.7083 Delayed Data As of Mar 22 |  +0.0487 / +7.30%Today’s Change | 0.50 Today|||52-Week Range 1.62 | +34.02% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 1.8K | 0.00 | 0.00 | 0.00 | |
| Cost of Goods Sold | 132.4K | 0.00 | 0.00 | 0.00 | ||
| Depreciation And Amortization | 272.6K | 303.5K | 129.0K | 44.2K | ||
| Operating Expenses | Gross Income | -403.3K | -303.5K | -129.0K | -44.2K | |
| General Expenses | 12.4M | 6.9M | 7.1M | 11.4M | ||
| Research And Development | 2.4M | 770.4K | 2.3M | 4.2M | ||
| Total Operating Expenses | 12.8M | 7.2M | 7.2M | 11.4M | ||
| Non-Operating Expenses | Operating Income | -12.8M | -7.2M | -7.2M | -11.4M | |
| Extraordinary Credit | 0.00 | 1.8M | 0.00 | 0.00 | ||
| Extraordinary Charge | 0.00 | -719.0K | -742.5K | 0.00 | ||
| Interest Expense On Debt | -- | 0.00 | 192.8K | 0.00 | ||
| Other Expenses | 430.00 | -163.2K | 150.00 | 29.3K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -12.8M | -6.4M | -8.1M | -11.4M | |
| Preferred Dividend | 0.00 | 0.00 | -2.6M | -11.5M | ||
| Discontinued Operations | -2.3M | 0.00 | 0.00 | 0.00 | ||
| Extraordinary Items | -670.9K | 0.00 | 0.00 | 0.00 | ||
| Net Income | -15.1M | -6.4M | -8.1M | -11.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 157.9K | 245.6K | 974.8K | 4.2M | |
| Shares To Calculate EPS Diluted | 157.9K | 245.6K | 974.8K | 4.2M | ||
| Earnings Per Share | EPS | -$99.00 | -$25.92 | -$10.92 | -$5.50 | |
| EPS Diluted | -$95.54 | -$25.93 | -$10.92 | -$5.50 | ||
